H2 PHARMA CONSULTING LIMITED
Active Company no. 06206575 Incorporated Apr 2007 ME postcode area
The Carriage House, Mill Street, Maidstone, ME15 6YE
The most recent insolvency notice for H2 PHARMA CONSULTING LIMITED is a Appointment of liquidators (MVL), published 21 August 2026 in The London Gazette. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
As at 30 April 2025 · total exemption full accounts · unaudited · filed 15 months before the first insolvency notice
Total liabilities is not shown for this company: the filed balance sheet did not reconcile against the figures we could read, so the total would be incomplete.
Average employees during the period: 3
Insolvency notices (3)
-
Appointment of liquidators (MVL) 21 Aug 2026
The notice announces the appointment of two joint liquidators for H2 PHARMA CONSULTING LIMITED in a members voluntary liquidation.
-
Resolution for winding up (MVL) 21 Aug 2026
PHARMA CONSULTING LIMITED has passed a special resolution to voluntarily wind up the company and appointed two joint liquidators, Mark Holborow and Steven Edwards, on 17 August 2026.
-
Notices to creditors (MVL) 21 Aug 2026
The joint liquidators of H2 PHARMA CONSULTING LIMITED announce final creditor distributions in a members’ voluntary liquidation and state that any remaining funds will be paid to shareholders.
Owed money by H2 PHARMA CONSULTING LIMITED?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is H2 PHARMA CONSULTING LIMITED in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for H2 PHARMA CONSULTING LIMITED (company no. 06206575) is a Appointment of liquidators (MVL), published 21 August 2026 in The London Gazette.
What were H2 PHARMA CONSULTING LIMITED's last filed accounts?
H2 PHARMA CONSULTING LIMITED's last accounts filed at Companies House, to 30 April 2025, showed total assets of £1.1m, cash of £941k, net assets of £1.0m. For a distressed company the last filing often predates the insolvency by a year or more.
How many insolvency notices does H2 PHARMA CONSULTING LIMITED have?
H2 PHARMA CONSULTING LIMITED has 3 insolvency notices recorded in The London Gazette, the most recent being a Appointment of liquidators (MVL) on 21 August 2026.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.